New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
15:23 EDTPE, MYGN, FOSL, VSAT, URS, KING, LQ, JDSU, JKHY, CREENotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Cree (CREE), consensus 41c; King Digital (KING), consensus 59c; Fossil Group (FOSL), consensus 96c; Jack Henry (JKHY), consensus 60c; URS Corporation (URS), consensus 74c; Myriad Genetics (MYGN), consensus 46c; JDS Uniphase (JDSU), consensus 13c; ViaSat (VSAT), consensus 15c; Parsley Energy (PE), consensus 9c; La Quinta (LQ), consensus 11c.
News For CREE;KING;FOSL;JKHY;URS;MYGN;JDSU;VSAT;PE;LQ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
12:12 EDTMYGNMyriad Genetics receives FDA approval of BRACAnalysis CDx
Myriad Genetics (MYGN) announced that it has received approval from the U.S. FDA for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca's (AZN) drug Lynparza. Lynparza is the first poly ADP-ribose polymerase inhibitor for patients with germline mutations in BRCA1/2 advanced ovarian cancer who have had three or more lines of chemotherapy. BRACAnalysis CDx is Myriad's first FDA-approved companion diagnostic for use with a novel PARP inhibitor. BRACAnalysis CDx is a highly accurate molecular companion diagnostic test that identifies deleterious or suspected deleterious mutations in the BRCA1 and BRCA2 genes, using DNA obtained from a blood sample. BRACAnalysis CDx was proven in clinical studies to effectively identify patients with BRCA mutations who would be candidates for Lynparza. The approval of BRACAnalysis CDx demonstrates Myriad's commitment to developing companion diagnostics and is the culmination of an intensive, multiyear scientific collaboration with AstraZeneca to advance personalized medicine for women with ovarian cancer.
10:17 EDTMYGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:14 EDTKINGKing Digital volatility at high end of historic range
King Digital January and February call option implied volatility is at 72, May is at 64; compared to its 26-week average of 57 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on January 6.
07:15 EDTMYGNMyriad Genetics initiated with a Market Perform at Wells Fargo
Subscribe for More Information
December 18, 2014
10:01 EDTFOSLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:02 EDTPEParsley Energy downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
05:34 EDTFOSLFossil initiated with a Neutral at Goldman
Goldman Sachs started shares of Fossil with a Neutral rating citing slowing business momentum and new competition from smart watches. The firm has a 6-month price target of $113.
December 17, 2014
10:21 EDTMYGNMyriad denied appeal to block competing breast cancer tests, Bloombeg reports
Subscribe for More Information
December 16, 2014
12:52 EDTFOSLFossil initiated with an Outperform at Cowen
Target $135.
07:33 EDTCREECharles & Colvard, Cree enter into new exclusive supply agreement
Subscribe for More Information
December 15, 2014
12:12 EDTPEParsley Energy management to meet with Stephens
Subscribe for More Information
December 12, 2014
12:36 EDTJDSUSandell Asset comments on JDSU voting results
Sandell Asset Management issued the following statement after the release of final voting results from the JDS Uniphase 2014 Annual Meeting of Stockholders: “Sandell is encouraged by the support it received from JDSU stockholders, who together voted approximately 57.9 million shares 'AGAINST' current Director Martin Kaplan, or more than 34% of the shares voting at the Annual Meeting. Furthermore, Mr. Kaplan was elected with only 47% of total outstanding shares voting in his favor; approximately 35.4 million shares either voted to abstain or were broker non-votes. The fact that Sandell was able to generate such strong support without actively soliciting proxies from stockholders speaks in our view to the profound frustration of the investor base to the entrenchment actions taken by this company’s Board of Directors and its refusal to conduct a more fulsome process to unlock stockholder value. Sandell has appreciated its dialogue with the stockholders of JDSU, including conversations with some of the company’s largest institutional stockholders. Based on this dialogue, we feel that we have significantly heightened the awareness among stockholders of the company’s troubling governance practices, as well as focused the investor base’s fervent desire to see additional value delivered to the stockholders, who are the true owners of the company. Notably, calls for consolidation in the optical components industry are only growing louder, in our view reinforcing the need to conduct a formal sale process for the CCOP business. The formal communication of this sale process is paramount, as we believe most legitimate strategic acquirers will not dedicate the time and effort required to conduct due diligence and compose a credible offer for CCOP without the express consent from the company and the opening of a comprehensive data room. The fact that leading proxy advisory firm Institutional Shareholders Services noted how the actions of the company served to frustrate the exercise of shareholder rights, coupled with the resulting media attention criticizing the troubling steps that the Board had taken to impinge upon the shareholder franchise, should not go unheeded by the Board of Directors. Furthermore, we remind stockholders that the entire Board is up for election next year. These voting results should serve as a wake-up call to the Board of Directors that the stockholders will not sit idly by and allow their rights to be usurped, nor will stockholders allow the significant value associated with the company’s unique collection of assets to remain obstructed.”
December 11, 2014
12:54 EDTMYGNMyriad Genetics management to meet with William Blair
Subscribe for More Information
December 10, 2014
10:10 EDTPEHigh option volume stocks
Subscribe for More Information
07:45 EDTPEWells Fargo to hold a symposium
2014 Wells Fargo Energy Symposium is being held in New York on December 9-10; with webcasted company presentations to begin on December 10 at 8 am; not all company presentations may be webcasted. Webcast Link
December 9, 2014
14:57 EDTJDSUTelecom equipment stocks rally after Verizon CFO comments on wireless CapEx
Telecom equipment stocks, which opened lower, rallied after Verizon (VZ) CFO Fran Shammo said he sees wireless CapEx continuing to trend upward. Shammo, speaking at the UBS 42nd Annual Global Media And Communications Conference, said, "The day we start to cut wireless CapEx is the day we start to wonder where the future of this industry is going." Ciena (CIEN), JDSU (JDSU), and Finisar (FNSR) all reversed earlier losses. PRICE ACTION: In afternoon trading, Ciena is up 1.5%, JDS Uniphase is up 3.8%, and Finisar is up 4.5%. Verizon, which was downgraded this morning to Neutral from Buy by RW Baird, is trading down almost 5%.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use